Canada approves Cardiac Science's Powerheart:
This article was originally published in Clinica
Executive Summary
Cardiac Science has received the go-ahead to market its Powerheart hospital bedside defibrillator-monitor in Canada. The fully automatic device detects the onset of a life-threatening arrhythmias and delivers defibrillation in seconds without the aid of hospital staff. The product is already cleared for sale in Australia, Europe and in the US. The Irvine, California-based company says it began marketing the device in early 2000 since when, it has generated around $4.2 million in revenue based on the sale of 734 Powerheart systems and related accessories.